Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.

de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, Almeida IC, de Andrade SS, de Andrade JG, Martelli CM.

Lancet. 1996 Nov 23;348(9039):1407-13.

PMID:
8937280
2.

Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.

Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comandé D, Ciapponi A, Sosa-Estani S.

PLoS One. 2015 Oct 5;10(10):e0139363. doi: 10.1371/journal.pone.0139363. eCollection 2015. Review.

3.

Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.

Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C.

Am J Trop Med Hyg. 1998 Oct;59(4):526-9.

4.

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

Molina I, Gómez i Prat J, Salvador F, Treviño B, Sulleiro E, Serre N, Pou D, Roure S, Cabezos J, Valerio L, Blanco-Grau A, Sánchez-Montalvá A, Vidal X, Pahissa A.

N Engl J Med. 2014 May 15;370(20):1899-908. doi: 10.1056/NEJMoa1313122.

5.

Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up.

Andrade AL, Martelli CM, Oliveira RM, Silva SA, Aires AI, Soussumi LM, Covas DT, Silva LS, Andrade JG, Travassos LR, Almeida IC.

Am J Trop Med Hyg. 2004 Nov;71(5):594-7.

6.

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.

Yun O, Lima MA, Ellman T, Chambi W, Castillo S, Flevaud L, Roddy P, Parreño F, Albajar Viñas P, Palma PP.

PLoS Negl Trop Dis. 2009 Jul 7;3(7):e488. doi: 10.1371/journal.pntd.0000488.

7.

Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.

Chippaux JP, Clavijo AN, Santalla JA, Postigo JR, Schneider D, Brutus L.

Trop Med Int Health. 2010 Jan;15(1):87-93. doi: 10.1111/j.1365-3156.2009.02431.x. Epub 2009 Nov 23.

8.

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras.

Escribà JM, Ponce E, Romero Ade D, Viñas PA, Marchiol A, Bassets G, Palma PP, Lima MA, Zúniga C, Ponce C.

Mem Inst Oswaldo Cruz. 2009 Nov;104(7):986-91.

9.

Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.

Rumi MM, Pérez Brandán C, Gil JF, D'Amato AM, Ragone PG, Lauthier JJ, Tomasini N, Cimino RO, Orellana V, Lacunza CD, Nasser JR, Basombrío MA, Diosque P.

Acta Trop. 2013 Oct;128(1):130-6. doi: 10.1016/j.actatropica.2013.07.003. Epub 2013 Jul 20.

PMID:
23880286
10.

Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.

Pinto AY, Valente Vda C, Coura JR, Valente SA, Junqueira AC, Santos LC, Ferreira AG Jr, de Macedo RC.

PLoS One. 2013 May 27;8(5):e64450. doi: 10.1371/journal.pone.0064450. Print 2013.

11.

Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.

Manarin R, Lamas MC, Bottasso E, Serra E, Revelli S, Salomón CJ.

Parasitol Int. 2013 Feb;62(1):79-81. doi: 10.1016/j.parint.2012.09.001. Epub 2012 Sep 10.

PMID:
22975280
12.

Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.

Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A.

Ann Intern Med. 2006 May 16;144(10):724-34.

PMID:
16702588
13.

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.

Garcia S, Ramos CO, Senra JF, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, Ribeiro-Dos-Santos R, Soares MB.

Antimicrob Agents Chemother. 2005 Apr;49(4):1521-8.

14.
15.

Chagas' disease: lymphoma growth in rabbits treated with Benznidazole.

Teixeira AR, Córdoba JC, Souto Maior I, Solórzano E.

Am J Trop Med Hyg. 1990 Aug;43(2):146-58.

PMID:
2117856
16.

Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission.

Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL.

Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):484-7.

17.

Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction.

Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, Candia N, Calcena MF, Figueredo A.

Am J Trop Med Hyg. 1998 Sep;59(3):487-91.

18.

Tolerance of benznidazole in treatment of Chagas' disease in adults.

Pinazo MJ, Muñoz J, Posada E, López-Chejade P, Gállego M, Ayala E, del Cacho E, Soy D, Gascon J.

Antimicrob Agents Chemother. 2010 Nov;54(11):4896-9. doi: 10.1128/AAC.00537-10. Epub 2010 Sep 7.

19.

[Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].

Moretti E, Cervetta L, Basso B, Castro I, Santamarina N.

Bol Chil Parasitol. 1998 Jan-Jun;53(1-2):3-9. Spanish.

PMID:
9830716
20.

Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.

Perez-Mazliah DE, Alvarez MG, Cooley G, Lococo BE, Bertocchi G, Petti M, Albareda MC, Armenti AH, Tarleton RL, Laucella SA, Viotti R.

J Antimicrob Chemother. 2013 Feb;68(2):424-37. doi: 10.1093/jac/dks390. Epub 2012 Oct 26.

Items per page

Supplemental Content

Write to the Help Desk